Zoar Limited (ZOAR)
NYSE: ZOARHealthcareDrug Manufacturers - GeneralUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ZOAR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $608.40M
- P/E (TTM)
- 7.86
- EPS (TTM)
- $0.43
- Dividend yield
- None
- 52-week range
- 3.26 – 6.72
- Day range
- 3.26 – 4.05
- Volume / Avg
- 21.95K / 31.40K
- Beta
- —
- Shares outstanding
- 180.00M
52-week range
ZOAR stock today
On Nov 20, ZOAR ended the session at $3.38, shedding $0.98 (22.48%), versus the S&P 500's 3.70% decline. At this level, ZOAR sits near the bottom of its 52-week range of $3.26 to $6.72: 49.7% below the high, set on Nov 18, 2026 and 3.7% above the low. Zoar trades at 7.9x its trailing twelve-month earnings per share of $0.43.
Summary generated from market data by MetaCap's automated system. Methodology
About Zoar
Company profileZoar Limited, a pharmaceutical company, engages in the development, manufacturing, and distribution of pharmaceutical ingredients (APIs) and intermediates in Africa, the Middle East, India, Central and South America, Asia, and Europe. The company offers APIs for anti-cancer, respiratory diseases, malaria, and cardiovascular health; and orphan drugs for rare diseases. It also provides drug contract development and manufacturing services to pharmaceutical companies.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Headquarters
- Hung Hom
- IPO year
- 2026
- Website
- zoarlimited.com
ZOAR news
All ZOAR newsIndexes, lists and sector
Appears in lists
Largest Healthcare stocks
Zoar stock FAQ
What is Zoar's stock price today?
ZOAR last traded at $3.38 as of Nov 20, 4:00 PM EST, down 22.48% on the day. Prices are delayed at least 15 minutes.
What is ZOAR's P/E ratio?
ZOAR trades at a trailing P/E ratio of 7.86.
What is the ZOAR 52-week high?
The 52-week high for ZOAR is $6.72 and the 52-week low is $3.26. The stock is currently 49.7% below its high.